Shanu Modi

Credentials: · · ·

History

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · First of 39 authors · 2,268 citations
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
New England Journal of Medicine · 2020 · First of 26 authors · 1,630 citations
Unlocking the potential of antibody-drug conjugates for cancer therapy
Review · Nature Reviews Clinical Oncology · 2021 · 949 citations

PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2017–2021
T-Cell Therapy for Advanced Breast Cancer
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2016–2027
Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2015–2021
Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2014–2021